INTRODUCTION
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Tamrakar BK, et al. Vitammi D Level in RA pain, swelling, anemia, loss of appetite and weight loss. Its pathogenesis is still under investigation, although the role of genetic susceptibility, environmental factors, and immune activation is indispensable 1, 2, 3, 4 . However, in more severe case it can cause irreversible damage of joints and can also cause damage in other body organs such as eyes, lungs, blood vessels and skin. Therefore, biomarkers are required for early diagnosis to prevent the damage. RA factor and anti-cyclic citrullinated peptide (anti-CCP) antibody are most commonly used biomarkers to diagnose RA. But anti-CCP antibody has been found to be more specific for RA than RA factor 5 . Anti-CCP antibodies, auto-antibodies found in sera of RA patients has been found to be more reliable than RA factor for diagnosing rheumatoid arthritis which is detectable in very early stage of the disease 6 . Early diagnosis may help to prevent the irreversible damage of joints 7, 8 . Vitamin D, also known as secosteroid is a fat-soluble hormone, which can be generated following ultraviolet light irradiation of the skin and plays vital role in metabolism of bone and calcium. Furthermore, it also plays role in modulation of cell growth, neuromuscular and immune function, and reduction of inflammation. 25-hydroxy vitamin D deficiency is linked to rickets among children and osteomalacia and osteoporosis among adults 9 . Deficiency of vitamin D is involved in the pathogenesis of RA, as well as activity of RA. The decrease of vitamin D is related to older age, female gender and a higher degree of RA activity 10, 11 . Hilger J et al. reported that prevalence of vitamin D level in the context of Asia/Pacific region is significantly lower level
12
. Song et al. found that in a meta-analysis, involvement of vitamin D at the onset of RA 10 . They found that individuals with the highest level of vitamin D intake from food had a 24% lower risk of developing RA than those in the lowest group. However, in another study vitamin D intake was not associated with the risk of RA 13 . Thus, present study aimed to determine the level of 25-hydroxy vitamin D in RA patients and assess the relationship between serum vitamin D and anti-CCP antibody levels in patients with newly diagnosed RA.
METHODS
The study subjects of 63 RA patients (29 males and 34 females) were recruited in between January 2017 to February 2018, from the Internal Medicine Department, Fishtail Hospital and Research Centre, Pokhara, Nepal.
Newly diagnosed RA patients with disease duration of less than one year and had not been treated with non-steroidal anti-inflammatory drugs. All enrolled patients fulfilled the American college of Rheumatology or European league against rheumatism RA classification criteria. Apparently 56 healthy individuals (26 males and 30 females) of the region having either no health problem or not receiving any therapeutic treatment were used as the normal control group. All the subjects in RA group and control group were consented by the Institutional Review Board of the Hospital to participate in the study. At the time of sample collection information regarding demography, lifestyle and health/medical history was recorded in the predesigned questionnaire.
The following blood tests were evaluated in the blood serum at the Department of Laboratory of Fishtail Hospital and Research Centre. Blood sample were drawn aseptically from cubital vein. A total of 5.0 ml of venous blood was drawn from each subject. Blood samples were allocated in plane tube and EDTA tube. EDTA blood used for erythrocyte sedimentation rates (ESR) by automated machine, sedy-12 ESR analyzer, unique diagnostics. Clotted bloods allocated in plane tube were then centrifuged at 2000 rpm for 10 minutes to separate serum samples and glucose, creatinine, uric acid, and calcium were measured using standard protocol in both RA and control group by fully automated biochemistry analyzer. RF test, 25-hydroxy vitamin D, and anti-CCP antibody were measured in serum sample of RA group, however, only serum 25-hydroxy vitamin D levels were measured in the control group. Qualitative RF in serum was determined by latex agglutination method (Medsource Ozone Biomedicals). Serum 25-hydroxy vitamin D levels and Anti-CCP levels were measured by an automated electrochemiluminescent immunoassay from Siemens Immunoassay system. Vitamin D status was defined as follows: ≥30 ng/mL, sufficiency; <29 ng/mL, ≥21 ng/mL, insufficiency; ≤20 ng/mL, deficiency and for anti-CCP testing, a level of ≥25 relative units IU/mL was considered positive 14, 15 .
Statistical analysis
The statistical analysis was under taken using SPSS version 20.0 software. Quantitative data were expressed as mean ±SD. Student t-test was used to compare quantitative data of two groups. Chi square test was applied for qualitative data analysis and one way ANOVA was used to compare the differences between different sub groups. The level of significance was considered when p value <0.05 was considered as cut off value for significance.
RESULTS
Total of 63 RA patients fulfilled the American college of Rheumatology or European league against rheumatism RA classification criteria and age, sex matched 56 healthy control groups was included in the study. Out of 63 RA patients, males were 29 (46%) and females were 34 (54%), whereas, in control group 26 (41%) males and 30 (48%) were females. The comparison of anthropometric parameters age, SBP, DBP, BMI, Waist/Hip ratio are summarized in Table 1 . The mean age of the RA patient 52.8 ±13.6 and control group 49.7 ±11.9 showed a nonsignificant difference (P=0.09). Systolic blood pressure (SBP) and diastolic blood pressure (DBS) was noted statistically non significant between RA and control group.
The mean of both BMI and waist hip ration was noted statistically non significant in between two groups. 
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DISCUSSION
The comparison of anthropometric parameters age, SBP, DBP, BMI, waist/hip ratio are not statistically significant in between RA and control group suggesting that these parameters are not associated with rheumatoid arthritis.
There was significantly higher level of uric acid in RA group than control group (5.63 ±0.81 Vs 4.28 ±0.59, P=0.04) suggested that uric acid play a role in the pathogenesis of arthritis. Anti-CCP antibody, are used as highly sensitive marker in the diagnosis and severity evaluation of RA. In the present study, we found that increased anti-CCP and decreased ESR in RA than control are accepted results.
We have found that vitamin D deficiency
(25-hydroxyvitamin D) values <20 ng/mL is common in RA patients affecting 47% of the entire cohort. Our results are similar to various report presented in smaller sizes, with a prevalence of vitamin D deficiency ranging from 30 -63% 16, 17, 18 . In the present study 25-hydroxyvitamin D levels were in insufficiency level (24.46 ±8.45) even in control groups, suggesting that the level of vitamin D is slightly lower in Nepalese population, which may be due to food and personal behavior. Also the normal ranges of vitamin D we use are acquired from Western counties. Our results shows significant decrease of vitamin D in RA than control group, confirms the correlation between rheumatoid arthritis and vitamin D. We suggest that vitamin D may play the crucial role in the formation of arthritis and recent studies have highlighted on the immunological activity of vitamin D, which is independent of its classical role in the regulation of calcium 19 .
We demonstrated negatively correlated serum 25-hydroxyvitamin D levels to the anti-CCP antibody levels. Anti-CCP antibody, early marker of RA can be used as an indicator for supplementation treatment of vitamin D in the early rheumatoid arthritis patients. However, anti-CCP antibodies were shown to have no correlation with serum 25-hydroxyvitamin D in chronic RA patients 20 .
In our study, we have enrolled the first diagnose early RA patients and our results are as similar to the recent work, where serum 25-hydroxyvitamin D levels were reduced in patients with RA and negatively associated with disease activity 21 . Moreover, intake of vitamin D can lower the risk of RA 10 .
CONCLUSION
In RA patient vitamin D deficiency is quite common and serum 25-OH-D level was negatively correlated to anti-CCP antibody level. Our results suggest that vitamin D level is a motivation factor rather than a consequence of RA activity. Further studies on the role of vitamin D in the pathogenesis of RA are required.
